Benfotiamine (rINN, or S-benzoylthiamine O-monophosphate) is a synthetic S-acyl derivative of thiamine (vitamin B1) that sold as a medication or dietary supplement to treat diabetic neuropathy. Combination drugs with pyridoxine or cyanocobalamin are also marketed. Benfotiamine was developed and invented in Japan then reported internationally by Wada, Takagi, Minakami et al. in 1961.

Property Value
dbo:abstract
  • Benfotiamine (rINN, or S-benzoylthiamine O-monophosphate) is a synthetic S-acyl derivative of thiamine (vitamin B1) that sold as a medication or dietary supplement to treat diabetic neuropathy. Combination drugs with pyridoxine or cyanocobalamin are also marketed. Benfotiamine was developed and invented in Japan then reported internationally by Wada, Takagi, Minakami et al. in 1961. (en)
dbo:thumbnail
dbo:wikiPageEditLink
dbo:wikiPageExtracted
  • 2019-09-10 16:04:47Z (xsd:date)
dbo:wikiPageHistoryLink
dbo:wikiPageID
  • 9791224 (xsd:integer)
dbo:wikiPageLength
  • 9953 (xsd:integer)
dbo:wikiPageModified
  • 2019-09-10 16:04:17Z (xsd:date)
dbo:wikiPageOutDegree
  • 32 (xsd:integer)
dbo:wikiPageRevisionID
  • 914993148 (xsd:integer)
dbo:wikiPageRevisionLink
dbp:wikiPageUsesTemplate
dct:subject
rdf:type
rdfs:comment
  • Benfotiamine (rINN, or S-benzoylthiamine O-monophosphate) is a synthetic S-acyl derivative of thiamine (vitamin B1) that sold as a medication or dietary supplement to treat diabetic neuropathy. Combination drugs with pyridoxine or cyanocobalamin are also marketed. Benfotiamine was developed and invented in Japan then reported internationally by Wada, Takagi, Minakami et al. in 1961. (en)
rdfs:label
  • Benfotiamine (en)
owl:sameAs
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is foaf:primaryTopic of